right-img

Home | Zacks: Analysts Expect Recro Pharma Inc (NASDAQ:REPH) Will Post Quarterly Sales of $19.83 Million

Zacks: Analysts Expect Recro Pharma Inc (NASDAQ:REPH) Will Post Quarterly Sales of $19.83 Million

September 30, 2019
Equities analysts expect Recro Pharma Inc (NASDAQ:REPH) to announce $19.83 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided estimates for Recro Pharma’s earnings, with the highest sales estimate coming in at $21.88 million and the lowest estimate coming in at $18.70 million. Recro Pharma posted sales […]
Read more at:https://www.americanbankingnews.com/2019/09/30/zacks-analysts-expect-recro-pharma-inc-nasdaqreph-will-post-quarterly-sales-of-19-83-million.html

Site Created by finaceandbankingnewsnow.com